News | January 06, 2026
Wegovy pill marks first GLP-1 weight-loss medicine in oral form
The approval introduces a needle-free alternative to injectable GLP-1 therapies
The approval introduces a needle-free alternative to injectable GLP-1 therapies
The SNS records neural activity from 60 channels across four brain regions—far exceeding current commercial devices
Abbott’s latest innovation promises to shift diabetes management from reactive to proactive
The company said it received notice on January 1 from the FDA’s Center for Veterinary Medicine that the funding will support its ongoing effectiveness study of Canalevia-CA1
Syrma Johari is a globally recognised medical device engineering and manufacturing organisation
The approval is supported by data from three pivotal clinical trials
Dr. Chand held several leadership positions within AstraZeneca and the broader biopharmaceutical industry
Dr. Bandichhor brings nearly two decades of experience from Dr. Reddy's Laboratories
Singh previously served as Head of IT (Development and Manufacturing Services) at Syngene International Limited, Lead of IT Manufacturing at UPL, and AGM at The Hi-Tech Gears
The decision secures legal protection in China for semaglutide, the blockbuster drug underpinning Novo Nordisk’s diabetes and obesity treatments
Subscribe To Our Newsletter & Stay Updated
